Results 1 to 10 of about 51,657 (292)

Developing Galectin-3-Targeted Therapeutics in Diseases: Three Distinct Galectin-3 Segments for Targeting [PDF]

open access: yesExpert Reviews in Molecular Medicine
The β-galactoside-binding protein galectin-3 is currently a hotly pursued therapeutic target in cancer, inflammation and fibrosis-associated diseases due to its multi-mode actions and broad impact on the pathogenesis and progress of the diseases. Various
Paulina Sindrewicz-Goral   +3 more
doaj   +2 more sources

Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor

open access: yesJournal for ImmunoTherapy of Cancer, 2021
Background PD-1/PD-L1 engagement and overexpression of galectin-3 (Gal-3) are critical mechanisms of tumor-induced immune suppression that contribute to immunotherapy resistance. We hypothesized that Gal-3 blockade with belapectin (GR-MD-02) plus anti-PD-
William L Redmond   +12 more
doaj   +1 more source

Chloroquine and cytosolic galectins affect endosomal escape of antisense oligonucleotides after Stabilin-mediated endocytosis

open access: yesMolecular Therapy: Nucleic Acids, 2023
Non-DNA-binding Stabilin-2/HARE receptors expressed on liver sinusoidal endothelial cells specifically bind to and internalize several classes of phosphorothioate antisense oligonucleotides (PS-ASOs).
Ekta Pandey, Edward N. Harris
doaj   +1 more source

Expression, Regulation, and Functions of the Galectin-16 Gene in Human Cells and Tissues

open access: yesBiomolecules, 2021
Galectins comprise a family of soluble β-galactoside-binding proteins, which regulate a variety of key biological processes including cell growth, differentiation, survival, and death.
Jennifer D. Kaminker   +1 more
doaj   +1 more source

αvβ1 integrin is enriched in extracellular vesicles of metastatic breast cancer cells: A mechanism mediated by galectin‐3

open access: yesJournal of Extracellular Vesicles, 2022
Breast cancer cells release a large quantity of biocargo‐bearing extracellular vesicles (EVs), which mediate intercellular communication within the tumour microenvironment and promote metastasis.
Daniel Xin Zhang   +16 more
doaj   +1 more source

The Cellular and Chemical Biology of Endocytic Trafficking and Intracellular Delivery—The GL–Lect Hypothesis

open access: yesMolecules, 2021
Lipid membranes are common to all forms of life. While being stable barriers that delimitate the cell as the fundamental organismal unit, biological membranes are highly dynamic by allowing for lateral diffusion, transbilayer passage via selective ...
Ludger Johannes
doaj   +1 more source

Galectinology of Equine Pregnancy

open access: yesAnimals, 2022
Galectins are a family of proteins that bind to glycans, acting in a cytokine-like manner throughout the body. In the majority of mammalians, galectins have been found to be involved in pregnancy maintenance, but few studies have evaluated this in the ...
Carleigh E. Fedorka   +2 more
doaj   +1 more source

Galectins can serve as biomarkers in COVID-19: A comprehensive systematic review and meta-analysis

open access: yesFrontiers in Immunology, 2023
BackgroundGalectins are an eleven-member class of lectins in humans that function as immune response mediators and aberrancies in their expression are commonly associated with immunological diseases.
Amir Hossein Behnoush   +7 more
doaj   +1 more source

“Repair Me if You Can”: Membrane Damage, Response, and Control from the Viral Perspective

open access: yesCells, 2020
Cells are constantly challenged by pathogens (bacteria, virus, and fungi), and protein aggregates or chemicals, which can provoke membrane damage at the plasma membrane or within the endo-lysosomal compartments.
Coralie F. Daussy, Harald Wodrich
doaj   +1 more source

Mutation of the galectin‐3 glycan‐binding domain (Lgals3‐R200S) enhances cortical bone expansion in male mice and trabecular bone mass in female mice

open access: yesFEBS Open Bio, 2022
We previously observed that genomic loss of galectin‐3 (Gal‐3; encoded by Lgals3) in mice has a significant protective effect on age‐related bone loss.
Kevin A. Maupin   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy